# Laurus Labs Limited – FDA Inspection, May 19, 2017

Source: https://www.keypedia.com/records/fda_inspections/laurus-labs-limited/60f5456b-a899-44d9-a901-ce8c8e44a566
Source feed: FDA_Inspections

> FDA inspection 1021004 of Laurus Labs Limited, May 19, 2017. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1021004
- Company Name: Laurus Labs Limited
- Inspection Date: 2017-05-19
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1197437 - 2023-02-10](https://www.keypedia.com/records/fda_inspections/laurus-labs-limited/87a91f56-c854-47f4-b20a-994500891253)
- FDA Inspection 1048158 - 2018-03-01
- [FDA Inspection 1005790 - 2016-12-01](https://www.keypedia.com/records/fda_inspections/laurus-labs-limited/7b30ded5-9bef-410c-930d-94a9bff8c132)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/azza-talaat/91f4d4f9-b0f3-4e9c-8c05-2bfe40507dfd)

Company: https://www.keypedia.com/companies/laurus-labs-limited/4112e7fd-7d8d-41bc-914f-6c705b2e47c7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
